Benefits Plans - Prescription Drug Plan: Drug Plan Updates and New Drug Releases - Drug Reviews
Following are the drug considerations that were reviewed and determined for formulary inclusion and Tier placement by the U-M Pharmaceutical Benefits Advisory Committee. The chart combines the April–July 2003 drug releases.
|Drug Name||Indication||Preferred Drug List||Action|
|Cardizem LA||Angina||Yes||Tier 3|
|Alinia||Diarrhea||No||Tier 2, ages 1-11 years only|
|Emend||Nausea||No||Tier 2, prior authorization required|
|Restasis||Tear Production||No||Tier 2|
The University of Michigan in its sole discretion may modify, amend, or terminate the benefits provided with respect to any individual receiving benefits, including active employees, retirees, and their dependents. Although the university has elected to provide these benefits this year, no individual has a vested right to any of the benefits provided. Nothing in these materials gives any individual the right to continued benefits beyond the time the university modifies, amends, or terminates the benefit. Anyone seeking or accepting any of the benefits provided will be deemed to have accepted the terms of the benefits programs and the university's right to modify, amend or terminate them.